Floatz logo

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-

Lung Cancer (NSCLC)

Shanghai Pulmonary Hospital, Shanghai, ChinaSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Lung Cancer (NSCLC) cohort.

Asset / SponsorPhaseRating
Capivasertib
Shanxi Province Cancer Hospital
Phase 2BB
NEPENTHE
Hacettepe University
Phase 4B
Tunlametinib
Sun Yat-sen University
Phase 2B
Jbi-802
The Christ Hospital
Phase 2CCC
Cetuximab
Sun Yat-sen University
Phase 2CCC

View all 13 →

Same molecule, other indications

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:

Alzheimer DementiaDormant
BB
Indicative ·
66 / 100
View asset →
Essential TremorDormant
B
Indicative ·
63 / 100
View asset →
Breast CancerDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →